TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
18,643
|
17,549
|
19,202 |
Financial expenses |
4,242
|
2,377
|
743 |
Earnings before taxes |
4,021
|
5,094
|
6,133 |
Total assets |
43,275
|
42,090
|
36,501 |
Current assets |
14,926
|
12,872
|
11,180 |
Current liabilities |
2,693
|
5,626
|
4,535 |
Equity capital |
24,895
|
22,965
|
18,013 |
- share capital |
2,651
|
2,798
|
2,654 |
Employees (average) | 32 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.5%
|
54.6%
|
49.3% |
Turnover per employee | 600 | ||
Profit as a percentage of turnover |
21.6%
|
29.0%
|
31.9% |
Return on assets (ROA) |
19.1%
|
17.8%
|
18.8% |
Current ratio |
554.3%
|
228.8%
|
246.5% |
Return on equity (ROE) |
16.2%
|
22.2%
|
34.0% |
Change turnover |
2,016
|
-2,696
|
5,104 |
Change turnover % |
12%
|
-13%
|
36% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.